JSJie Sun

Jie Sun

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jie Sun has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Anyu Tao

    Department of Medical Ultrasound, Tongji Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan China

    1 shared publication
  • Chengzhi Lu

    Department of Cardiology, Tianjin First Central Hospital, No.24 Fukang Road, Nankai District, Tianjin 300192, China

    1 shared publication
  • Die Zhao

    Department of Medical Psychology, The Basic Medicine College of Tianjin Medical University, No. 22 Qixiangtai Road, Heping District, Tianjin 300070, China

    1 shared publication
  • Jun Zhang

    Department of School of Nursing, Wuhan University, Wuhan City, Hubei, China

    1 shared publication
  • Junli Wang

    Institute of Sport Science and Innovations, Lithuanian Sports University, LT-44221 Kaunas, Lithuania

    1 shared publication
  • Kun Liu

    Burdon Sanderson Cardiac Science Centre and BHF Centre of Research Excellence, Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK

    1 shared publication

Latest Publications

  • Open Access

    Aldosterone Blockade in Acute Myocardial Infarction: A Systematic Review and Meta-Analysis

    by Qiao Chen, Die Zhao, Jie Sun, Chengzhi Lu

    Background. A comprehensive evaluation of the benefits of mineralocorticoid receptor antagonists (MRA) in acute myocardial infarction (AMI) patients is lacking. Objective. To summarize the evidence on the efficacy and safety of MRA in patients admitted for AMI. Methods. Articles were identified through PubMed, Embase, Cochrane Library, Ovid (Medline1946-2021), and ClinicalTrials.gov databases from their inception to December 31, 2020. Results. 15 articles with a total of 11,861 patients were included. MRA reduced the risk of all-cause mortality by 16% (relative ratio (RR): 0.84; 95% confidence interval (CI) (0.76, 0.94); ) and the incidence of cardiovascular adverse events by 12% (RR: 0.88, 95% CI (0.83, 0.93), ) in post-AMI patients, and further analysis demonstrated that early administration of MRA within 7 days after AMI resulted in a greater reduction in all-cause mortality (RR: 0.72, 95% CI (0.61, 0.85), ). Subgroup analyses showed that post-STEMI patients without left ventricular systolic dysfunction (LVSD) treated with MRA had a 36% reduction in all-cause mortality (RR: 0.64, 95% CI (0.46, 0.89), ) and a 22% reduction in cardiovascular adverse events (RR: 0.78, 95% CI (0.67, 0.91), ). Meanwhile, post-STEMI patients without LVSD treated with MRA get significant improvements in left ventricular ejection fraction (mean difference (MD): 2.69, 95% CI (2.44, 2.93), ), left ventricular end-systolic index (MD: -4.52 ml/m2, 95% CI (-8.21, -0.83), ), and left ventricular end-diastolic diameter (MD: -0.11 cm, 95% CI (-0.22, 0.00), ). The corresponding RR were 1.72 (95% CI (1.43, 2.07), ) for considered common adverse events (hyperkalemia, gynecomastia, and renal dysfunction). Conclusions. Our findings suggest that MRA treatment reduces all-cause mortality and cardiovascular adverse events in post-AMI patients, which is more significant in patients after STEMI without LVSD. In addition, MRA treatment may exert beneficial effects on the reversal of cardiac remodeling in patients after STEMI without LVSD.


  • GW24-e2904 Study on Aorta Elastic Properties in Experimental Mouse Model of Atherosclerosis by Ultra-High Frequency Ultrasound

    by Ya Liu NI, Kun Liu, Jie Sun, Ya Liu, Wei Zhou, Junli Wang, Anyu Tao, Youbin Deng

    Objectives: To assess the aorta elastic properties in the procession of atherosclerosis by ultra-high frequency ultrasound, and to detect whether there was a relationship between the aorta elastic properties and the severity of atherosclerotic plaque. Methods: Mice deficient for the ApoE with high-cholestrol diet (Apo E−/−) were studied as an age-dependent model of atherosclerosis. At 10, 20, 30 and 40 weeks of age, the blood pressure in the ascending aorta was measured by catheter, and the aorta mechanical properties were assessed by measuring aortic elastic modulus and pulse transit time of the ascending aorta with ultrahigh frequency ultrasound. The plaque burden was assessed by high-frequency ultrasound and Masson’s trichrome stain, separately. Results: Elastic modulus of the aorta (EAo) significantly increased from 10 to 40 wks of age, and there was also an age-dependent decrease in PTT in Apo E−/− mice. Vessel thickness at the lesion-prone sites of the lesser curvature of the aorta and the proximal brachiocephalic artery increased with age, consistent with the Masson’s trichrome staining which showed age-dependent worsening of atherosclerosis in the mice model. There was a statistically relationship between the aorta mechanical properties and the severity of plaque. Conclusions: With the progression of atherosclerosis and the increased plaque burden, aorta mechanical properties deteriorated in Apo E−/− mice. Ultra-high ultrasound was a potential tool for assessment of plaque burden and aorta mechanical properties in mouse model.